| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 1a
| Puntambekar S, Moutinho M, Lin P, Jadhav V, Tumbleson Brink D, Balaji A, et al. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease. Mol Neurodegener. 2022;17:47 pubmed publisher |
| Abd Elrahman K, Colson T, Sarasija S, Ferguson S. A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer's mice. Biomed Pharmacother. 2024;173:116388 pubmed publisher |
| Datta D, Perone I, Wijegunawardana D, Liang F, Morozov Y, ARELLANO J, et al. Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early-stage neurodegeneration. Alzheimers Dement. 2024;20:2843-2860 pubmed publisher |
| Huang Z, Gong Z, Lin Y, Yang F, Chen W, Xiang S, et al. Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer's disease prior to amyloid-beta deposition delays the disease's pathological development and ameliorates cognitive decline. Front Aging Neurosci. 2024;16:1267780 pubmed publisher |
| Marshall J, Huynh K, Lancaster G, Ng J, Collins J, Pernes G, et al. Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's disease. iScience. 2024;27:108800 pubmed publisher |
| He J, Liu Y, Li J, Zhao Y, Jiang H, Luo S, et al. Intestinal changes in permeability, tight junction and mucin synthesis in a mouse model of Alzheimer's disease. Int J Mol Med. 2023;52: pubmed publisher |
| Marinho D, Ferreira I, Lorenzoni R, Cardoso S, Santana I, Rego A. Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer's disease. Aging Cell. 2023;22:e13895 pubmed publisher |
| Chae C, Yoon J, Lim J, Park J, Cho J, Jung Y, et al. TRIM16-mediated lysophagy suppresses high-glucose-accumulated neuronal Aβ. Autophagy. 2023;19:2752-2768 pubmed publisher |
| Kim M, Kim S, Lee J, Kim J, Oh E, Kim S, et al. Lignan-Rich Sesame (Sesamum indicum L.) Cultivar Exhibits In Vitro Anti-Cholinesterase Activity, Anti-Neurotoxicity in Amyloid-β Induced SH-SY5Y Cells, and Produces an In Vivo Nootropic Effect in Scopolamine-Induced Memory Impaired Mice. Antioxidants (Basel). 2023;12: pubmed publisher |
| Li J, Hu T, Zhou X, Zhang T, Guo J, Wang M, et al. The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice. J Neuroinflammation. 2023;20:112 pubmed publisher |
| Panes Fernández J, Godoy P, Gavilan J, Ram xed rez Molina O, Burgos C, Marileo A, et al. TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease. Biomed Pharmacother. 2023;162:114596 pubmed publisher |
| Wang C, Shen D, Hu Y, Chen J, Liu J, Huang Y, et al. Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice. Int J Mol Sci. 2023;24: pubmed publisher |
| Tiwari V, Singh J, Tiwari P, Chaturvedi S, Gupta S, Mishra A, et al. ACE2/ANG-(1-7)/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer's disease-like phenotypes. Eur J Pharmacol. 2023;946:175623 pubmed publisher |
| Das S, Ramanan N. Region-specific heterogeneity in neuronal nuclear morphology in young, aged and in Alzheimer's disease mouse brains. Front Cell Dev Biol. 2023;11:1032504 pubmed publisher |
| Choi C, Kim H, Oh J, Park C, Kim M, Kim C, et al. DSCR1 deficiency ameliorates the Aβ pathology of Alzheimer's disease by enhancing microglial activity. Life Sci Alliance. 2023;6: pubmed publisher |
| Bhatia H, Brunner A, xd6 zt xfc rk F, Kapoor S, Rong Z, Mai H, et al. Spatial proteomics in three-dimensional intact specimens. Cell. 2022;185:5040-5058.e19 pubmed publisher |
| Dong Y, Cheng L, Zhao Y. Resetting the circadian clock of Alzheimer's mice via GLP-1 injection combined with time-restricted feeding. Front Physiol. 2022;13:911437 pubmed publisher |
| Ngwa D, Agrawal A. Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils. J Immunol. 2022;209:1180-1188 pubmed publisher |
| Bryois J, Calini D, Macnair W, Foo L, Urich E, Ortmann W, et al. Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. Nat Neurosci. 2022;25:1104-1112 pubmed publisher |
| Yao P, Parmar V, Choudhary M, Malek G. NURR1 expression regulates retinal pigment epithelial-mesenchymal transition and age-related macular degeneration phenotypes. Proc Natl Acad Sci U S A. 2022;119:e2202256119 pubmed publisher |
| Liu C, Sang Z, Pan H, Wu Q, Qiu Y, Shi J. A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer's Disease by Dual Inhibition of Acetylcholinesterase and Inflammation. Front Aging Neurosci. 2022;14:922650 pubmed publisher |
| Zhong Y, Zhang C, Wang Y, Tang C, Ren J, Wang M, et al. Multiple exposures to sevoflurane across postnatal development may cause cognitive deficits in older age. Pediatr Res. 2022;: pubmed publisher |
| Chen T, Lee S, Zheng W, Hsu C, Cho K, Kuo L, et al. White matter pathology in alzheimer's transgenic mice with chronic exposure to low-level ambient fine particulate matter. Part Fibre Toxicol. 2022;19:44 pubmed publisher |
| Simon M, Wang M, Ismail O, Braun M, Schindler A, Reemmer J, et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice. Alzheimers Res Ther. 2022;14:59 pubmed publisher |
| Tao R, Wang N, Shen T, Tan Y, Ren Y, Wei W, et al. High-fidelity imaging of amyloid-beta deposits with an ultrasensitive fluorescent probe facilitates the early diagnosis and treatment of Alzheimer's Disease. Theranostics. 2022;12:2549-2559 pubmed publisher |
| Wang J, Zhu X, Li Y, Zhang P, Wang T, Li M. Jiedu-Yizhi Formula Improves Cognitive Impairment in an Aβ 25-35-Induced Rat Model of Alzheimer's Disease by Inhibiting Pyroptosis. Evid Based Complement Alternat Med. 2022;2022:6091671 pubmed publisher |
| Hud xe1 k A, Letoha A, Vizler C, Letoha T. Syndecan-3 as a Novel Biomarker in Alzheimer's Disease. Int J Mol Sci. 2022;23: pubmed publisher |
| He Z, Huan P, Wang L, He J. Paeoniflorin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling. Metab Brain Dis. 2022;37:1057-1070 pubmed publisher |
| Walker J, Kazempour Dehkordi S, Fracassi A, Vanschoiack A, Pavenko A, Taglialatela G, et al. Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling. Acta Neuropathol Commun. 2022;10:23 pubmed publisher |
| Zhao X, Hasan S, Liou B, Lin Y, Sun Y, Liu C. Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice. Int J Mol Sci. 2022;23: pubmed publisher |
| Han J, Hyun J, Park J, Jung S, Oh Y, Kim Y, et al. Aberrant role of pyruvate kinase M2 in the regulation of gamma-secretase and memory deficits in Alzheimer's disease. Cell Rep. 2021;37:110102 pubmed publisher |
| Bhargavan B, Woollard S, McMillan J, Kanmogne G. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice. Mol Neurodegener. 2021;16:78 pubmed publisher |
| Rimal S, Li Y, Vartak R, Geng J, Tantray I, Li S, et al. Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease. Acta Neuropathol Commun. 2021;9:169 pubmed publisher |
| Tikhonova M, Amstislavskaya T, Ho Y, Akopyan A, Tenditnik M, Ovsyukova M, et al. Neuroprotective Effects of Ceftriaxone Involve the Reduction of Aβ Burden and Neuroinflammatory Response in a Mouse Model of Alzheimer's Disease. Front Neurosci. 2021;15:736786 pubmed publisher |
| Godoy P, Mennickent D, Cuchillo Ibanez I, Ramírez Molina O, Silva Grecchi T, Panes Fernández J, et al. Increased P2×2 receptors induced by amyloid-β peptide participates in the neurotoxicity in alzheimer's disease. Biomed Pharmacother. 2021;142:111968 pubmed publisher |
| Choi C, Park J, Kim H, Chang K, Park J, MIN K. DSCR1 upregulation enhances dural meningeal lymphatic drainage to attenuate amyloid pathology of Alzheimer's disease. J Pathol. 2021;255:296-310 pubmed publisher |
| Wang M, Feng L, Li Z, Ma K, Chang K, Chen X, et al. Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice. J Neuroinflammation. 2021;18:146 pubmed publisher |
| Yang Y, Zhang J, Yang X, Li Z, Wang J, Lu C, et al. Dysregulated APP expression and α-secretase processing of APP is involved in manganese-induced cognitive impairment. Ecotoxicol Environ Saf. 2021;220:112365 pubmed publisher |
| Souder D, Dreischmeier I, Smith A, Wright S, Martin S, Sagar M, et al. Rhesus monkeys as a translational model for late-onset Alzheimer's disease. Aging Cell. 2021;20:e13374 pubmed publisher |
| Hanna R, Flamier A, Barabino A, Bernier G. G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer's disease. Nat Commun. 2021;12:1828 pubmed publisher |
| Liu Y, Hanson K, McCormack G, Atkinson R, Dittmann J, Vickers J, et al. Enhanced Anti-Amyloid Effect of Combined Leptin and Pioglitazone in APP/PS1 Transgenic Mice. Curr Alzheimer Res. 2020;17:1294-1301 pubmed publisher |
| Fernández Pérez E, Gallegos S, Armijo Weingart L, Araya A, Riffo Lepe N, Cayumán F, et al. Changes in neuronal excitability and synaptic transmission in nucleus accumbens in a transgenic Alzheimer's disease mouse model. Sci Rep. 2020;10:19606 pubmed publisher |
| Balczon R, Morrow K, Leavesley S, Francis C, Stevens T, Agwaramgbo E, et al. Cystatin C regulates the cytotoxicity of infection-induced endothelial-derived β-amyloid. FEBS Open Bio. 2020;10:2464-2477 pubmed publisher |
| Heckmann B, Teubner B, Boada Romero E, Tummers B, Guy C, Fitzgerald P, et al. Noncanonical function of an autophagy protein prevents spontaneous Alzheimer's disease. Sci Adv. 2020;6:eabb9036 pubmed publisher |
| Hernández Rodríguez M, Arciniega Martinez I, García Marín I, Correa Basurto J, Rosales Hernández M. Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats. Mol Neurobiol. 2020;57:3979-3988 pubmed publisher |
| Acharya A, Stockmann J, Beyer L, Rudack T, Nabers A, GUMBART J, et al. The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure. Biophys J. 2020;119:349-359 pubmed publisher |
| Park S, Kang J, Lee T, Nam D, Jeon C, Kim J. SPON1 Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer's Disease Mouse Model. Cells. 2020;9: pubmed publisher |
| Voth S, Gwin M, FRANCIS C, Balczon R, Frank D, Pittet J, et al. Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions. FASEB J. 2020;34:9156-9179 pubmed publisher |
| Liu X, Deng Y, Dai Z, Hu T, Cai W, Liu H, et al. Sodium tanshinone IIA sulfonate protects against Aβ1-42-induced cellular toxicity by modulating Aβ-degrading enzymes in HT22 cells. Int J Biol Macromol. 2020;151:47-55 pubmed publisher |
| He Y, Ruganzu J, Lin C, Ding B, Zheng Q, Wu X, et al. Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice. Neurochem Int. 2020;133:104610 pubmed publisher |
| Joseph E, Villalobos Acosta D, Torres Ramos M, Farfán García E, Gómez López M, Miliar Garcia A, et al. Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer's Disease Model. J Mol Neurosci. 2020;70:180-193 pubmed publisher |
| Prokop S, Miller K, Labra S, Pitkin R, Hoxha K, Narasimhan S, et al. Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples. Acta Neuropathol. 2019;138:613-630 pubmed publisher |
| Balczon R, Pittet J, Wagener B, Moser S, Voth S, Vorhees C, et al. Infection-induced endothelial amyloids impair memory. FASEB J. 2019;33:10300-10314 pubmed publisher |
| Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, et al. Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease. Transl Neurodegener. 2019;8:15 pubmed publisher |
| El Hajjar J, Chatoo W, Hanna R, Nkanza P, Tétreault N, Tse Y, et al. Heterochromatic genome instability and neurodegeneration sharing similarities with Alzheimer's disease in old Bmi1+/- mice. Sci Rep. 2019;9:594 pubmed publisher |
| Cristiano C, Volpicelli F, Lippiello P, Buono B, Raucci F, Piccolo M, et al. Neutralization of interleukin-17 rescues amyloid-β-induced neuroinflammation and memory impairment. Br J Pharmacol. 2019;: pubmed publisher |
| Collins J, King A, Woodhouse A, Kirkcaldie M, Vickers J. Age moderates the effects of traumatic brain injury on beta-amyloid plaque load in APP/PS1 mice. J Neurotrauma. 2019;: pubmed publisher |
| Kim D, Lee D, Lim H, Choi S, Oh W, Yang Y, et al. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease. Biochem Biophys Res Commun. 2018;504:933-940 pubmed publisher |
| Woodhouse A, Fernández Martos C, Atkinson R, Hanson K, Collins J, O Mara A, et al. Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice. BMC Anesthesiol. 2018;18:47 pubmed publisher |
| Kim D, Lim H, Lee D, Choi S, Oh W, Yang Y, et al. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model. Sci Rep. 2018;8:354 pubmed publisher |
| Paspalas C, Carlyle B, Leslie S, Preuss T, Crimins J, Huttner A, et al. The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology. Alzheimers Dement. 2018;14:680-691 pubmed publisher |
| Muthukumaran K, Kanwar A, Vegh C, Marginean A, Elliott A, Guilbeault N, et al. Ubisol-Q10 (a Nanomicellar Water- Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease. J Alzheimers Dis. 2017;: pubmed publisher |
| Lee D, Hwang C, Choi J, Park M, Song M, Oh K, et al. KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer's disease models. Oncotarget. 2017;8:68654-68667 pubmed publisher |
| Stuart K, King A, Fernandez Martos C, Summers M, Vickers J. Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer's model. Sci Rep. 2017;7:2764 pubmed publisher |
| Balczon R, Morrow K, Zhou C, Edmonds B, Alexeyev M, Pittet J, et al. Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids. FASEB J. 2017;31:2785-2796 pubmed publisher |
| Stuart K, King A, Fernandez Martos C, Dittmann J, Summers M, Vickers J. Mid-life environmental enrichment increases synaptic density in CA1 in a mouse model of A?-associated pathology and positively influences synaptic and cognitive health in healthy ageing. J Comp Neurol. 2017;525:1797-1810 pubmed publisher |
| Yu Y, Hsieh T, Chen K, Wu J, Hoffer B, Greig N, et al. Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats. J Neurotrauma. 2016;33:2044-2054 pubmed |
| Collins J, King A, Woodhouse A, Kirkcaldie M, Vickers J. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Exp Neurol. 2015;267:219-29 pubmed publisher |
| Kim J, Yun H, Jin P, Lee H, Han J, Udumula V, et al. Inhibitory effect of a 2,4-bis(4-hydroxyphenyl)-2-butenal diacetate on neuro-inflammatory reactions via inhibition of STAT1 and STAT3 activation in cultured astrocytes and microglial BV-2 cells. Neuropharmacology. 2014;79:476-87 pubmed publisher |
| Youmans K, Tai L, Nwabuisi Heath E, JUNGBAUER L, Kanekiyo T, Gan M, et al. APOE4-specific changes in A? accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem. 2012;287:41774-86 pubmed publisher |
| Youmans K, Tai L, Kanekiyo T, Stine W, Michon S, Nwabuisi Heath E, et al. Intraneuronal A? detection in 5xFAD mice by a new A?-specific antibody. Mol Neurodegener. 2012;7:8 pubmed publisher |
